Medicine · Diabetes Mellitus and Endocrine Disorders (Thyroid, Adrenal, Pituitary, Parathyroid)

A 28-year-old man has hypokalemia (K+ 2.8), hypertension, metabolic alkalosis, and suppressed plasma renin activity. Plasma aldosterone-to-renin ratio (ARR) is markedly elevated. Adrenal CT shows bilateral adrenal hyperplasia. The FIRST-LINE medical treatment for this subtype of primary hyperaldosteronism is:

  • A Fludrocortisone
  • B Amiloride
  • C Spironolactone or eplerenone
  • D Dexamethasone
Correct answer: C. Spironolactone or eplerenone

Explanation

Bilateral adrenal hyperplasia causing primary aldosteronism is treated medically with mineralocorticoid receptor antagonists — spironolactone (first-line) or eplerenone (fewer anti-androgenic side-effects). Surgery is appropriate for unilateral aldosteronoma confirmed on adrenal venous sampling. Dexamethasone is reserved for glucocorticoid-remediable aldosteronism (familial type I). Amiloride is a second-line potassium-sparing alternative.

Reference: Harrison's Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Diabetes Mellitus and Endocrine Disorders (Thyroid, Adrenal, Pituitary, Parathyroid) MCQs

See all Diabetes Mellitus and Endocrine Disorders (Thyroid, Adrenal, Pituitary, Parathyroid) MCQs →